Navigation Links
The Micell Rapid Absorption Polymer DES System to be Presented at TCT 2008
Date:10/10/2008

RALEIGH, N.C., Oct. 10 /PRNewswire/ -- Micell Technologies announced today that David E. Kandzari, MD, will present "The Micell Rapid Absorption Polymer DES System" during the Drug-Eluting Stent Summit at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, DC, on October 13, 2008. The MiStent(TM), a drug-eluting stent in pre-clinical studies, utilizes a bioresorbable polymer coating that delivers the potential therapeutic benefits of the drug during the healing process. The drug and polymer are both eliminated from the stent within 90 days.

"The Micell DES technology is exciting because it is the first of a new generation of stents being developed to precisely deliver a drug while safely eliminating the polymer faster than any other biodegradable coating that is commercially available," said Kandzari. "The controlled drug release and kinetics enables a lower drug dose while using known and proven polymers and an approved anti-proliferative drug. Taken together, the Micell DES has the potential to offer the therapeutic benefit of a drug-eluting stent and the safety profile of a bare metal stent."

Dr. Kandzari is the Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, CA.

About Micell Technologies

Micell Technologies is a privately-held, early-stage biomedical company dedicated to applying its unique surface and polymer modification technologies for improved patient benefits for medical device and drug delivery applications. Its first product, MiStent(TM), is a rapid absorbing coated drug-eluting stent (DES) with precise control of drug release and pharmacokinetics. To learn more, please visit our website at http://www.micell.com.

Contact: James McClain Ph.D., Chief Technology Officer

Micell Technologies: (919) 313-2111


'/>"/>
SOURCE Micell Technologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
2. Varian Medical Systems Exhibits a New Version of RapidArc(TM) Radiotherapy Technology and Other Products for Fast, Precise Cancer Treatment
3. Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008
4. Eklin Medical Surpasses 1,000th RapidStudy(R) Digital Radiography System Installation Featuring Canon DR Technology
5. Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
6. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
7. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
8. NanoLogix Inc. Announces Joint Development With CL Solutions and First Sales of Rapid Detection Kits
9. Cardium Announces InnerCools New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
10. NanoInterventions Launches New, Rapid Testing System for Coronary Stents
11. Enhanced Protein Tomography(TM) Method for Rapid Epitope Determination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sept. 2, 2015 Research and ... addition of Jain PharmaBiotech,s new report ... their offering. An increasing ... biotechnology industries is anticipated. Nanotechnology will be ... - from formulations for optimal delivery to ...
(Date:9/2/2015)... Research and Markets ... Jain PharmaBiotech,s new report "Biomarkers - Technologies, ... This report follows the broad definition of ... objectively measured and evaluated as an indicator of ... pharmacological responses to a therapeutic intervention. Tests based ...
(Date:9/2/2015)... 2015  Neurotech Pharmaceuticals, Inc., announced today the ... Phase 2 clinical trial of NT-503 Encapsulated Cell ... subfoveal choroidal neovascularization secondary to age related macular ... endothelial growth factor (VEGF) receptor protein continuously produced ... landmark proof-of-concept study will evaluate NT-503 ECT as ...
(Date:9/2/2015)... Israel , September 2, 2015 ... the intent of the National Institute of Allergy and Infectious ... (NIH) within the Department of Health and Human Services (HHS), ... in the United States in the ... universal flu vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... Biological Sciences Research Council (BBSRC) have taken a step ... disease of livestock - after successfully assembling the virus ... 2011) in the journal Proceedings of the National ... tools to develop vaccines with useful new properties. ...
... German . , In light of the increasing demand ... for manufacturers to understand just how these particles influence bodily ... which there has been a dearth of knowledge. Studies on ... a negative effect on the cardiovascular system. Yet, it remained ...
... , the leading life sciences employment and news website, ... the campaign,s eighth edition. (Logo: http://photos.prnewswire.com/prnh/20040907/CLTU006LOGO ... across Kansas, Illinois, Indiana, Iowa, Michigan, Minnesota, Missouri, Nebraska, ... an electronic and printed campaign map that ...
Cached Biology Technology:Scientists take a step towards developing better vaccines for bluetongue 2Scientists take a step towards developing better vaccines for bluetongue 3Artificial nanoparticles influence the heart rate 2Artificial nanoparticles influence the heart rate 3BioSpace Spotlights the Growing Midwest Life Science Community 2
(Date:9/2/2015)... September 2, 2015 ... implied in a system which uses identical human ... iris, vein, DNA and finger print. Increasing number ... develop such system which provides high level of ... Patterns and tokens are vulnerable to attacks. Furthermore, ...
(Date:8/26/2015)... India , August 26, 2015 ... Three, Four, and Five Factor), Application (Travel & Immigration, ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... Billion by 2020, growing at a CAGR of 17.7% ... Tables and 82 F igures spread through 169 ...
(Date:8/20/2015)... CLARA, Calif. , Aug. 20, 2015 /PRNewswire/ ... company focused on improving the user experience and ... and vision technologies, today announced that its ... voice biometric authentication software to be FIDO ... tested TrulySecure for compliance with the FIDO UAF ...
Breaking Biology News(10 mins):Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 2Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 3Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5
... of Medicine have made major discoveries that could lead to ... mouse study, the team located key molecules that switch on ... when parts of these pathways were blocked with a pain ... findings are published online ahead of print in the March ...
... chemistry experiment, in which beautiful plant-like structures sprout in a ... that aim to shed light on the origins of life ... could have kick-started life are the topic of a story ... . C&EN is the weekly newsmagazine of the American Chemical ...
... 20, 2013 - Elsevier, a world-leading provider of scientific, ... to announce the launch of Wound Medicine ... Research and Applications . Published in print ... is devoted to the clinical, scientific and health ...
Cached Biology News:Researchers spot molecular control switch for preterm lung disorders 2Elsevier announces the launch of a new journal: Wound Medicine 2
...
... 5-OxoETE-d7 is used as an internal standard ... isotope dilution mass spectrometry. 5-OxoETE is a ... of 5-HETE in human neutrophils. It stimulates ... EC50 of 2 nM. 5-OxoETE selectively stimulates ...
Mouse monoclonal antibody raised against a full length recombinant ATF3. NCBI Entrez Gene ID = ATF3...
... The pAcAB4 vector is a 10.0 kb ... contains two,copies of the AcNPV polyhedrin promoter ... the first p10,promoter is a Sma I ... sequences. Upstream of this,an inverted polyhedrin promoter ...
Biology Products: